Health care startups that raised Series C in Beijing, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| QL Biopharma | Beijing | Series C | $44.7M | 2026-09-14 |
| Diyingjia Technology | Beijing | Series C | $3.0M | 2026-07-28 |
| Darwin Cell Biology | Beijing | Series C | $27.9M | 2025-12-08 |
| Cipher Gene Tech | Beijing | Series C | $13.8M | 2024-05-27 |
| Digital Precision Medical (DPM) | Beijing | Series C | $27.8M | 2024-01-22 |
| Quanteng Medical | Beijing | Series C | $13.7M | 2023-09-19 |
| Huiyi Huiying | Beijing | Series C | $15.2M | 2020-11-16 |
| yuguo.cn | Beijing | Series C | $4.7M | 2018-05-31 |
8 rows of the CSV in 5 of its 18 columns.
- The 43 health care startups in Beijing, China whose last round is Series C have raised $1.4B in total.
- 7 of them closed their most recent round in the last 12 months, $136.4M combined.
- The largest of those rounds is QL Biopharma's $44.7M Series C, dated September 2026.
- The most recent is Zhishu Technology's $30.0M Series C on 21 October 2026.
- Microsoft Accelerator is an investor in 2 of them, more than any other fund.
- Biotech is the most common other sector, with 17 companies (40%).
- 0% were founded in 2020 or later; the median founding year is 2014.
- The most common team size is 101 to 250 employees (29% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
4 of 43| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| QL Biopharma | QL Biopharma develops recombinant protein drugs to treat chronic metabolic diseases. | Biotech | Series C | $44.7M | 2026-09-14 | $173.7M | Chengdu Science and Technology Venture Capital, TF Capital, Lichen Capital +1 | 101 to 250 | 2018 |
| Diyingjia Technology | Diyingjia Technology develops artificial intelligence software for medical imaging and treatment applications. | Artificial intelligence | Series C | $3.0M | 2026-07-28 | $32.3M | IDG Capital, Legend Capital, Microsoft Accelerator | 11 to 50 | 2017 |
| Darwin Cell Biology | Darwin Cell Biology provides cell biotechnology services. | Biotech | Series C | $27.9M | 2025-12-08 | $62.4M | Shijingshan Modern Innovation Industry Fund, Shanghai Yungu Investment | 11 to 50 | 2016 |
| Cipher Gene Tech | Cipher Gene Tech operates a biomedical big data analysis and interpretation platform. | Health care | Series C | $13.8M | 2024-05-27 | Everest Venture Capital, Shenzhen Guozhong Venture Capital Management, Microsoft Accelerator +1 | 11 to 50 | 2015 |
Table 1. Health care startups that raised Series C in Beijing, China: the 4 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 43.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | QL Biopharma | QL Biopharma develops recombinant protein drugs to treat chronic metabolic diseases. | Biotech | Series C | $44.7M | 2026-09-14 | $173.7M | Chengdu Science and Technology Venture Capital, TF Capital, Lichen Capital +1 | 101 to 250 | 2018 |
| 2 | Darwin Cell Biology | Darwin Cell Biology provides cell biotechnology services. | Biotech | Series C | $27.9M | 2025-12-08 | $62.4M | Shijingshan Modern Innovation Industry Fund, Shanghai Yungu Investment | 11 to 50 | 2016 |
| 3 | Diyingjia Technology | Diyingjia Technology develops artificial intelligence software for medical imaging and treatment applications. | Artificial intelligence | Series C | $3.0M | 2026-07-28 | $32.3M | IDG Capital, Legend Capital, Microsoft Accelerator | 11 to 50 | 2017 |
Table 2. Health care startups that raised Series C in Beijing, China: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Microsoft Accelerator | Startup accelerator | Beijing, China | 2 | 5% | 1 | Diyingjia Technology |
| 2 | BlueRun Ventures | Venture capital firm | San Mateo, United States | 2 | 5% | ||
| 3 | U.S.-China Green Fund | Private equity firm | Beijing, China | 1 | 2% | 1 | QL Biopharma |
| 4 | Chengdu Science and Technology Venture Capital | Venture capital firm | Chengdu, China | 1 | 2% | 1 | QL Biopharma |
| 5 | TF Capital | Venture capital firm | Pudong, China | 1 | 2% | 1 | QL Biopharma |
| 6 | Lichen Capital | Private equity firm | 1 | 2% | 1 | QL Biopharma | |
| 7 | Legend Capital | Venture capital firm | Beijing, China | 1 | 2% | 1 | Diyingjia Technology |
| 8 | IDG Capital | Private equity firm | Beijing, China | 1 | 2% | 1 | Diyingjia Technology |
| 9 | Shanghai Yungu Investment | Venture capital firm | Shanghai, China | 1 | 2% | 1 | Darwin Cell Biology |
| 10 | Shijingshan Modern Innovation Industry Fund | Fund of funds | Shijingshan, China | 1 | 2% | 1 | Darwin Cell Biology |
| 11 | Shenzhen Capital Group | Venture capital firm | Nanshan, China | 1 | 2% | ||
| 12 | Alwin Capital | Venture capital firm | Beijing, China | 1 | 2% | ||
| 13 | Zhongguancun Science City Science | Venture capital firm | Haidian, China | 1 | 2% | ||
| 14 | CS Capital | Private equity firm | Shanghai, China | 1 | 2% | ||
| 15 | Everest Venture Capital | Venture capital firm | Beijing, China | 1 | 2% |
Table 3. Health care startups that raised Series C in Beijing, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 17 | 40% | $1.0B |
| Software | 7 | 16% | $104.7M |
| Hardware | 3 | 7% | $133.3M |
| Artificial intelligence | 3 | 7% | $90.3M |
| Energy | 1 | 2% | $30.0M |
| Education | 1 | 2% | $13.6M |
| Commerce | 1 | 2% |
Table 4. Health care startups that raised Series C in Beijing, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series C | 43 | 100% | $27.0M |
Table 5. Health care startups that raised Series C in Beijing, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 14% | $30.0M |
| September 2026 | 1 | 14% | $44.7M |
| July 2026 | 1 | 14% | $3.0M |
| February 2026 | 1 | 14% | $14.4M |
| December 2025 | 3 | 43% | $44.3M |
Table 6. Health care startups that raised Series C in Beijing, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 4 | 9% | $92.1M |
| 2025 | 4 | 9% | $44.3M |
| 2024 | 2 | 5% | $41.6M |
| 2023 | 2 | 5% | $27.3M |
| 2022 | 4 | 9% | $61.0M |
| 2021 | 10 | 23% | $217.0M |
Table 7. Health care startups that raised Series C in Beijing, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2015 to 2019 | 18 | 42% |
| 2010 to 2014 | 17 | 40% |
| Before 2010 | 8 | 19% |
Table 8. Health care startups that raised Series C in Beijing, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 4 | 10% |
| 11 to 50 | 9 | 22% |
| 51 to 100 | 6 | 15% |
| 101 to 250 | 12 | 29% |
| 251 to 500 | 4 | 10% |
| 501 to 1,000 | 4 | 10% |
| 1,001 to 5,000 | 1 | 2% |
| 5,001 to 10,000 | 1 | 2% |
Table 9. Health care startups that raised Series C in Beijing, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series C and its headquarters is in Beijing, China. On 16 November 2026 that is 43 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 4 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 43 rows: 11 have no round amount, 0 no city and 13 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Beijing, China whose last round is Series C are on the list?
- 43, in the file dated 16 November 2026. 7 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 43 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.